Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung cancer biomarker testing: perspective from Europe.
Thunnissen E, Weynand B, Udovicic-Gagula D, Brcic L, Szolkowska M, Hofman P, Smojver-Ježek S, Anttila S, Calabrese F, Kern I, Skov B, Perner S, Dale VG, Eri Z, Haragan A, Leonte D, Carvallo L, Prince SS, Nicholson S, Sansano I, Ryska A. Thunnissen E, et al. Among authors: ryska a. Transl Lung Cancer Res. 2020 Jun;9(3):887-897. doi: 10.21037/tlcr.2020.04.07. Transl Lung Cancer Res. 2020. PMID: 32676354 Free PMC article. Review.
Molecular testing in lung cancer in the era of precision medicine.
Popper HH, Ryska A, Tímár J, Olszewski W. Popper HH, et al. Among authors: ryska a. Transl Lung Cancer Res. 2014 Oct;3(5):291-300. doi: 10.3978/j.issn.2218-6751.2014.10.01. Transl Lung Cancer Res. 2014. PMID: 25806314 Free PMC article. Review.
Minimal requirements for the molecular testing of lung cancer.
Popper HH, Tímár J, Ryska A, Olszewski W. Popper HH, et al. Among authors: ryska a. Transl Lung Cancer Res. 2014 Oct;3(5):301-4. doi: 10.3978/j.issn.2218-6751.2014.10.02. Transl Lung Cancer Res. 2014. PMID: 25806315 Free PMC article. Review.
Testing for ROS1 in non-small cell lung cancer: a review with recommendations.
Bubendorf L, Büttner R, Al-Dayel F, Dietel M, Elmberger G, Kerr K, López-Ríos F, Marchetti A, Öz B, Pauwels P, Penault-Llorca F, Rossi G, Ryška A, Thunnissen E. Bubendorf L, et al. Among authors: ryska a. Virchows Arch. 2016 Nov;469(5):489-503. doi: 10.1007/s00428-016-2000-3. Epub 2016 Aug 17. Virchows Arch. 2016. PMID: 27535289 Free PMC article. Review.
NSCLC molecular testing in Central and Eastern European countries.
Ryska A, Berzinec P, Brcic L, Cufer T, Dziadziuszko R, Gottfried M, Kovalszky I, Olszewski W, Oz B, Plank L, Timar J. Ryska A, et al. BMC Cancer. 2018 Mar 9;18(1):269. doi: 10.1186/s12885-018-4023-4. BMC Cancer. 2018. PMID: 29523116 Free PMC article.
Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.
Ryska A, Buiga R, Fakirova A, Kern I, Olszewski W, Plank L, Seiwerth S, Toth E, Zivka E, Thallinger C, Zielinski C, Brcic L. Ryska A, et al. Oncologist. 2018 Dec;23(12):e152-e158. doi: 10.1634/theoncologist.2018-0008. Epub 2018 Aug 3. Oncologist. 2018. PMID: 30076278 Free PMC article.
Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples.
Keppens C, Dequeker EMC, Rouleau E, 't Hart N, Bubendorf L, Dufraing K, Garrec C, Guéguen P, Lamy A, Marchetti A, Pauwels P, Ryska A, Tack V, Tornillo L, Van Casteren K, von der Thüsen JH, Zwaenepoel K, Lissenberg-Witte B, Thunnissen E, Schuuring E. Keppens C, et al. Among authors: ryska a. BMC Cancer. 2020 May 1;20(1):366. doi: 10.1186/s12885-020-06831-3. BMC Cancer. 2020. PMID: 32357863 Free PMC article.
220 results